abiraterone,olaparib
astrazeneca,merck
['propel', 'gu ', '$mrk', 'merck', 'astrazeneca', '$azn']
$azn $mrk - astrazeneca and merck present final results of key secondary overall survival endpoint from phase iii propel trial at asco gu cancers symposium 
Follow for the latest #healthcare #stockmarket tweets. Visit https://t.co/wA5OfUn0Ee to try our powerful investing tools.